Effect of domain interaction on apolipoprotein E levels in mouse brain

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Apolipoprotein E4 (apoE4) is a known risk factor for Alzheimer's disease and other neurodegenerative conditions.
• The structural difference of domain interaction in apoE4, compared to apoE2 and apoE3, leads to faster protein turnover and reduced plasma levels.
• The precise mechanisms linking apoE4 to neurodegeneration remain largely unknown.

Purpose of the Study:

• To investigate whether the domain interaction characteristic of apoE4 influences apoE levels within the brain.
• To determine if this structural property is responsible for reduced apoE concentrations observed in the brain.

Main Methods:

• Analysis of brain homogenates and cerebrospinal fluid (CSF) from human apoE3 and apoE4 knock-in mice, wild-type mice, and genetically modified Arg-61 apoE mice.
• Western blot analysis to quantify apoE levels in different brain regions (hemibrain, cortex, hippocampus, cerebellum).
• Assessment of apoE mRNA levels and analysis of apoE secretion from primary astrocyte cultures.

Main Results:

• Knock-in mice exhibited 30-40% lower apoE4 levels than apoE3 in brain homogenates.
• Arg-61 apoE mice showed 25-50% lower apoE levels in the brain and 40% lower levels in CSF compared to wild-type mice.
• ApoE mRNA levels did not correlate with protein levels, and primary astrocytes secreted less Arg-61 apoE and apoE4.

Conclusions:

• Domain interaction is the primary cause of reduced apoE4 and Arg-61 apoE levels in the mouse brain.
• Cells may identify apoE4 and Arg-61 apoE as misfolded proteins, leading to their degradation or accumulation.
• The lower brain apoE levels associated with apoE4 may contribute to its established link with Alzheimer's disease pathogenesis.